A traceless directing group assisted Co-catalyzed C(sp2)–H carbonylation of ortho-arylanilines for the synthesis of free (NH)-phenanthridinones in metal-based-oxidant-free fashion was accomplished. This protocol employs diisopropyl azodicarboxylate as the CO source and oxygen as the sole oxidant, and provides good yields with various functional tolerance. The methodology has been applied for the total
Rhodium(I)-Catalyzed Aryl C–H Carboxylation of 2-Arylanilines with CO<sub>2</sub>
作者:Yuzhen Gao、Zhihua Cai、Shangda Li、Gang Li
DOI:10.1021/acs.orglett.9b01105
日期:2019.5.17
An unprecedented Rh(I)-catalyzed, amino-group-assisted C–H carboxylation of 2-arylanilines with CO2 under redox-neutral conditions has been developed. This reaction was promoted by a phosphine ligand with t-BuOK as the base and did not require the use of additional strong organometallic reagent. It enabled an efficient direct conversion of a broad range of 2-(hetero)arylanilines including electron-deficient
An efficient synthesis of free (NH)-phenanthridinones through Pd-catalyzed C(sp(2))-H aminocarbonylation of unprotected o-arylanilines under an atmospheric pressure of CO has been developed. Some ortho heteroarene substituted anilines as well as N-alkyl protected o-arylanilines are also suitable substrates for this C-H aminocarbonylation reaction.
Phenanthridinone derivatives have been prepared in good to high yields via palladium-catalyzed cyclization of readily available N-benzyl-N-benzoyl-o-iodoanilides.
PHENANTHRIDINE MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
申请人:McDaniel Keith F.
公开号:US20120295842A1
公开(公告)日:2012-11-22
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.